# LEVETIRACETAM
> **ANDA214815** · Abbreviated New Drug Application (Generic) · Sponsor: MSN · Approved 2022-10-07
## Drug
- **FDA Application Number:** ANDA214815
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LEVETIRACETAM
- **Generic name:** LEVETIRACETAM
- **Active ingredients:** LEVETIRACETAM
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** MSN
- **Manufacturer:** Novadoz Pharmaceuticals LLC
- **First approval:** 2022-10-07
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214815)
---
*AI Analytics · CC0 1.0*